APR 15, 2016 07:11 AM PDT

How Healthy Cells Become Cancer's Unwitting Allies

In what sounds like an epic fantasy battle between good and evil, researchers at the University of Manchester, UK found that cancer cells don’t act alone, but can coerce healthy cells to join the ‘dark side.’ The power of coercion lays in the mutated version of a cancer driver gene called KRAS, which allows cancer cells to persuade healthy cells to secrete growth signals to enable their uncontrolled proliferation. The study provides new information about how cancer cells affect healthy cells, and how this communication loop could be exploited in future cancer treatments.
Communication between cancer cell (left) and healthy cell (right)
 The KRAS gene encodes a protein that’s part of a signaling pathway known as the RAS/MAPK pathway, which is involved in cell division and differentiation. Because of its functions in cell growth, mutations in KRAS are often associated with many types of cancers. In particular, the researchers were interested in pancreatic ductal adenocarcinoma, a form of pancreatic cancer whereby KRAS mutations are found over 90% of the time.
Using cells that carry KRAS mutations, the team analyzed the secreted signals from the tumor cells. These signals included growth factors, cytokines, and receptors, which influenced the regulation of nearby cells. In particular, when they looked at the relationship between a healthy cell nearby a tumor cell, the team noticed that healthy cells were persuaded to respond in an unexpected way – they secreted growth factors for the cancer cells’ use. With the signals from the healthy cells, cancer cells doubled the potential of KRAS to become even more malignant.
 “What our research underlines is that cancer cells do not drive the growth and spread of tumors alone – they can bully their healthy neighbors into helping them,” said Chris Tape, Sir Henry Wellcome Research Fellow at the Institute of Cancer Research, and first study author.

The cells susceptible to the cancer cells’ influence were stromal cells, which include fat and connective cells that provide structural support for tissues and organs. The communication loop between cancer cells and stromal cells effectively coerces these healthy cells to become cancer’s unwitting allies.
And knowing how this happens could be key to finding new drug targets. “Some pancreatic tumors have more healthy stromal cells within them than they do cancer cells, so understanding how cancer cells turn their neighbors into allies is critically important. We have discovered exactly how cancer cells can persuade stromal tissue to secrete key growth signals, and in doing so opened up exciting new possibilities for treatment," said Tape. 

Additional source: ICR UK, MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 17, 2018
JUL 17, 2018
Large Multifactorial NIH Study Announced for Prostate Cancer Aggressiveness in African-American Men
The largest coordinated study on Prostate cancer aims to look at both genetic and environmental factors that lead to increased risk and cancer aggressiveness in African-American men compared...
AUG 13, 2018
AUG 13, 2018
What does sunscreen look like with a UV camera?
  Have you ever wondered if there’s really a difference between SPF 30 and SPF 50? You’re not the only one. YouTuber Physics Girl set out...
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Combination Therapy for Advanced Melonoma
According to a research study led by UCLA, a bacteria-like agent used in combination with an immunotherapeutic drug may help patients survive longer with a...
AUG 29, 2018
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
OCT 21, 2018
OCT 21, 2018
New Technology Detects Early-Stage Lung Cancer
According to recent research published in the Journal of Molecular Diagnostics, outcomes of patients with non-small-cell lung carcinoma (NSCLC) may be impr...
OCT 29, 2018
OCT 29, 2018
Gut: a second brain and novel therapeutic target
Undersatnding the role of gut microbiome in disease pathologies and targetting them for potential treatment strategies....
Loading Comments...